JAZZ - Jazz Pharma slips as mid-stage trial for neuro candidate fails
2024-06-20 08:14:15 ET
More on Jazz Pharmaceuticals
- Jazz Pharmaceuticals plc (JAZZ) Q1 2024 Earnings Call Transcript
- Jazz Pharmaceuticals plc 2024 Q1 - Results - Earnings Call Presentation
- Jazz Pharmaceuticals: Cheap But Complicated
- Goldman starts Jazz at buy, cites diversified portfolio
- Jazz presents additional phase 2 data on zanidatamab for biliary tract cancer